MassMutual Private Wealth & Trust’s TG Therapeutics TGTX Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio TGTX Stock Details TGTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.83K	Sell	88 -26	-23%	-$1.06K	﹤0.01%	1699
2026 Q1	$3.79K	Buy	114 +5	+5%	+$149	﹤0.01%	1774
2025 Q4	$3.25K	Sell	109 -1	-0.9%	-$33	﹤0.01%	1846
2025 Q3	$3.97K	Sell	110 -56	-34%	-$1.84K	﹤0.01%	1761
2025 Q2	$5.97K	Buy	166 +6	+4%	+$223	﹤0.01%	1565
2025 Q1	$6.31K	Buy	160 +71	+80%	+$2.39K	﹤0.01%	1491
2024 Q4	$2.68K	Buy	89 +3	+3%	+$86	﹤0.01%	1746
2024 Q3	$2.01K	Buy	+86	New	+$1.88K	﹤0.01%	1663
2023 Q3	–	Sell	-10	Closed	-$248	–	2051
2023 Q2	$248	Buy	+10	New	+$258	﹤0.01%	1860
2020 Q4	–	Sell	-1,000	Closed	-$27K	–	942
2020 Q3	$27K	Hold	1,000	–	–	﹤0.01%	473
2020 Q2	$19K	Hold	1,000	–	–	﹤0.01%	477
2020 Q1	$10K	Hold	1,000	–	–	﹤0.01%	526
2019 Q4	$11K	Hold	1,000	–	–	﹤0.01%	613
2019 Q3	$6K	Buy	+1,000	New	+$6.97K	﹤0.01%	666

Other funds holding TGTX

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

PCM

Penn Capital Management Philadelphia, Pennsylvania $1.58B AUM 81.2% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

ACM

ACT Capital Management Wayne, Pennsylvania $153M AUM

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return

MassMutual Private Wealth & Trust's TGTX Position: Q2 2026 in Review

MassMutual Private Wealth & Trust reduced its TG Therapeutics (TGTX) stake by 23% in Q2 2026, selling an estimated $1.06K and leaving 88 shares worth $4.83K. The position accounts for ﹤0.01% of the portfolio, ranked #1699.

MassMutual Private Wealth & Trust first reported a position in TGTX in Q3 2019 and has held it in 14 quarters since. The position peaked at $27K in Q3 2020. 143 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

MassMutual Private Wealth & Trust held 88 shares of TG Therapeutics worth $4.83K as of Q2 2026.
MassMutual Private Wealth & Trust sold 26 TG Therapeutics shares in Q2 2026, an estimated $1.06K.
TG Therapeutics made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #1699 holding.
MassMutual Private Wealth & Trust first reported a position in TG Therapeutics in Q3 2019 and has held it in 14 quarters since.
MassMutual Private Wealth & Trust's TG Therapeutics position peaked at $27K in Q3 2020.
143 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.